Photoselected TEV Protease Variants for Faster Specific Cleavage

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The slow catalytic turnover of the TEV protease limits the performance of biotechnological applications, such as FLARE, which requires faster catalysis for temporal resolutions of minutes or seconds, a goal unachievable with wild-type TEV.

Innovation Solution

Directed evolution of TEV proteases using yeast strains with fusion proteins and photoinducible protein binding pairs to enhance catalytic activity, including C-terminal truncated TEV variants and LOV domains, allowing for increased catalytic efficiency.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If wild-type TEV protease is used, then sequence-specificity is maintained, but catalytic rate is too slow for applications requiring temporal resolution of minutes or seconds

Engineering Contradiction:
Improvecatalytic rateVSAvoidsequence-specificity
Core Design Contradiction:
SpeedVSReliability

Solution Approach 1:

The patent applies directed evolution to change the amino acid sequence parameters of TEV protease, generating variants with improved catalytic rates. Specific mutations in the protease sequence alter its kinetic properties (kcat) while preserving its ability to recognize and cleave the TEV consensus sequence ENLYFQS, thus resolving the contradiction between speed and specificity.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If C-terminal truncated TEV variants are used, then catalytic efficiency is increased, but protein stability may be reduced

Engineering Contradiction:
Improvecatalytic efficiencyVSAvoidprotease stability
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent removes the C-terminal portion of the TEV protease sequence to generate truncated variants. This extraction of the C-terminal region eliminates structural elements that may constrain catalytic activity, thereby increasing catalytic efficiency while the core catalytic domain remains intact to maintain sufficient stability for biotechnological applications.

Inventive Principle:
Principle #2Taking out (Extraction)

3Loss of time

If directed evolution is applied to improve catalytic rate, then temporal resolution is achieved, but system complexity increases

Engineering Contradiction:
Improvetemporal resolutionVSAvoidevolution system complexity
Core Design Contradiction:
Loss of timeVSDevice complexity

Solution Approach 1:

The patent employs directed evolution in yeast systems where the protease variants are expressed and selected based on their catalytic performance in vivo. The system self-optimizes through selection pressure, allowing the identification of high-performance variants without requiring complex external characterization assays, thus reducing the practical complexity of the overall process.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The modified TEV proteases exhibit improved catalytic rates, enabling faster and more efficient proteolysis in applications like FLARE and SPARK, achieving temporal resolutions of seconds.

Implementation Method 1

A yeast strain is provided, the yeast comprising: (a) a first fusion protein comprising: (i) a first member of a photoinducible protein binding pair; (ii) a TEV protease that cleaves the proteolytically cleavable linker

Methodology Applied
Scientific EffectPhotoinducible protein binding:

Implementation Method 2

a TEV protease that cleaves the proteolytically cleavable linker

Methodology Applied
Scientific EffectProteolytic cleavage: Enzyme

Data Source

PatentUS12590325B2Directed evolution for obtaining improved variants of TEV protease for biotechnological applications
Publication Date: 2026.03.31 CZ BIOHUB SF LLC
  • US12590325B2 patent drawing
  • US12590325B2 patent drawing
  • US12590325B2 patent drawing

AI summary

Tobacco etch virus protease (TEV) is one of the most widely used proteases in biotechnology because of its exquisite sequence-specificity. A limitation of TEV is its slow catalytic rate, which limits product generation and therefore signal output. Provided is a generalizable yeast-based platform for directed evolution of protease catalytic properties. Protease activity is determined via proteolytic release of a membrane-anchored transcription factor, and access to TEV's cleavage site is temporally regulated using a photosensory LOV domain. By gradually decreasing light exposure time, faster variants of TEV were selected over multiple rounds of selection. The mutant TEV proteases and the directed evolution platform are useful in a wide range of biotechnology applications, such as FLARE and SPARK tools.